Correlation Between AbbVie and Gan Shmuel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AbbVie and Gan Shmuel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Gan Shmuel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Gan Shmuel, you can compare the effects of market volatilities on AbbVie and Gan Shmuel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Gan Shmuel. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Gan Shmuel.

Diversification Opportunities for AbbVie and Gan Shmuel

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between AbbVie and Gan is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Gan Shmuel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gan Shmuel and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Gan Shmuel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gan Shmuel has no effect on the direction of AbbVie i.e., AbbVie and Gan Shmuel go up and down completely randomly.

Pair Corralation between AbbVie and Gan Shmuel

Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the Gan Shmuel. But the stock apears to be less risky and, when comparing its historical volatility, AbbVie Inc is 4.02 times less risky than Gan Shmuel. The stock trades about -0.16 of its potential returns per unit of risk. The Gan Shmuel is currently generating about 0.36 of returns per unit of risk over similar time horizon. If you would invest  170,151  in Gan Shmuel on January 24, 2024 and sell it today you would earn a total of  70,249  from holding Gan Shmuel or generate 41.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy85.0%
ValuesDaily Returns

AbbVie Inc  vs.  Gan Shmuel

 Performance 
       Timeline  
AbbVie Inc 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in AbbVie Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable fundamental drivers, AbbVie is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Gan Shmuel 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Gan Shmuel are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Gan Shmuel sustained solid returns over the last few months and may actually be approaching a breakup point.

AbbVie and Gan Shmuel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AbbVie and Gan Shmuel

The main advantage of trading using opposite AbbVie and Gan Shmuel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Gan Shmuel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gan Shmuel will offset losses from the drop in Gan Shmuel's long position.
The idea behind AbbVie Inc and Gan Shmuel pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEOs Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data